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Purpose: Retinal pigment epithelium-specific protein 65 kDa (RPE65) plays an essential role in vitamin A metabolism
necessary for synthesizing the visual pigment 11-cis-retinal chromophore. Mutations in RPE65 cause the childhood
blindness disorder known as Leber congenital amaurosis (LCA), as well as autosomal recessive retinitis pigmentosa (RP).
The purpose of this study was to identify RPE65 mutations in Chinese patients with LCA, determine the prevalence of
RPE65 mutations in this cohort, and assess the clinical features of those patients with RPE65 mutations.
Methods: Detailed ocular examinations were performed, and genomic DNA was isolated with standard methods for
genetic diagnosis. All 14 exons of RPE65 were amplified with PCR and screened for mutation with direct DNA sequencing.
Two hundred unrelated healthy Chinese subjects were screened to exclude nonpathogenic polymorphisms. Multiple
alignments of eight eukaryotic RPE65 orthologs were performed.
Results: A total of 101 LCA patients, drawn from 100 unrelated families, were selected for mutation screening in the
RPE65 gene. Compound heterozygous missense mutations Leu67Arg and Tyr368Cys were identified in two affected
sisters and segregated with their family. Four previously reported polymorphisms were identified in this study. No other
disease-related mutation was detected. The frequency spectrum of variations in the RPE65 gene was estimated to be 1%
(1/100) in this cohort of Chinese patients with LCA. The two patients showed classical signs of LCA with relatively
preserved central vision and retinal structure.
Conclusions: The RPE65 mutation is a rare cause of LCA in the Chinese population. Compound heterozygous missense
mutations Leu67Arg and Tyr368Cys are related to a relatively mild LCA phenotype. Genetic characterization of patients
with RPE65 mutations is important for future rational therapies.
Leber  congenital  amaurosis  (LCA,  OMIM  204000)
represents a severe form of inherited retinal dystrophy that
accounts for 5% of all inherited retinopathies [1]. LCA is
generally  inherited  in  an  autosomal  recessive  manner
although  some  autosomal  dominant  families  have  been
reported [2-4]. LCA is characterized by congenital blindness,
nystagmus,  and  severely  reduced  or  nondetectable
electroretinogram (ERG) [1,5]. In addition, affected children
sometimes have oculodigital sign, which refers to repetitive
pressing, poking and rubbing their eyes with fingers or fists.
However,  certain  phenotypic  variations  have  also  been
identified in patients with LCA, including heterogeneity in
retinal appearance, refractive errors, and photosensitivity [6].
Clinical heterogeneity may reflect the genetic heterogeneity
of this retinal disorder.
LCA has been associated with mutations in 17 genes
(RetNet).  These  genes  have  been  discovered  by  various
methods,  including  linkage  analysis,  the  candidate  gene
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approach,  and  homozygosity  mapping.  The  identified
functions  of  the  proteins  encoded  by  these  genes  are
remarkably  heterogeneous,  including  participation  in  the
phototransduction cascade, structure of the photoreceptors,
the retinoid cycle, RNA splicing, and so on [7]. Among the
known disease genes, missense mutations in retinal pigment
epithelium-specific protein 65 kDa (RPE65) were identified
in  a  patient  with  LCA  type  II  using  the  candidate  gene
approach [8]. The RPE65 gene contains 14 coding exons
spanning 20 kb and encodes the isomerase enzyme necessary
for converting all-trans-retinol to 11-cis-retinal in the visual
cycle [9]. According to published reports, the prevalence of
RPE65 mutations ranges from 1.7% to 16% in LCA cohorts
from various geographical origins, with higher frequencies
reported in the United States [10-12].
To date, more than 80 LCA-associated RPE65 mutations
have been identified (HGMD). Most of the previous genetic
studies on LCA were performed in the Western population,
and only limited data are available from Chinese patients
[13].  The  purpose  of  this  study  is  to  analyze  the  RPE65
mutations in a cohort of Chinese patients with LCA and to
describe detailed clinical features of patients with LCA with
RPE65 mutations.
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744METHODS
Recruitment of subjects: All participants were identified at the
Ophthalmic Genetics Clinic at Peking Union Medical College
Hospital  (PUMCH),  Beijing,  China.  LCA  was  defined  as
severe  visual  impairment  within  the  first  year  after  birth,
nystagmus,  oculodigital  sign,  and  severely  reduced  or
nondetectable ERG. Family members of the probands were
invited for a clinical and genetic assessment. Written informed
consent was obtained either from the participating individuals
or  their  guardians.  This  study  was  approved  by  the
Institutional Review Board of PUMCH and adhered to the
tenets of the Declaration of Helsinki and the Guidance on
Sample  Collection  of  Human  Genetic  Diseases  by  the
Ministry of Public Health of China.
Clinical evaluations: A full medical and family history was
taken  and  ophthalmological  examination  performed.  Each
patient  underwent  standard  ophthalmic  examination:  best
corrected visual acuity according to Snellen charts, slit-lamp
biomicroscopy,  dilated  indirect  ophthalmoscopy,  fundus
photography if possible, and visual field tests. The retinal
structure was examined with optical coherence tomography
(OCT;  Topcon,  Tokyo,  Japan).  ERGs  were  performed
(RetiPort  ERG  system;  Roland  Consult,  Wiesbaden,
Germany) using corneal “ERGjet” contact lens electrodes.
The ERG protocol complied with the standards published by
the International Society for Clinical Electrophysiology of
Vision (ISCEV).
Genetic studies: Genomic DNA was isolated from peripheral
leukocytes using a QIAamp DNA Blood Midi Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s protocol.
All 14 coding exons, including intron-exon boundaries of the
RPE65  gene,  were  amplified  with  PCR  using  primers
published previously [10]. After purification, amplicons were
sequenced using forward and reverse primers on an ABI 3730
Genetic Analyzer (ABI, Foster City, CA). Sequences were
assembled and analyzed using Lasergene SeqMan software
(DNASTAR, Madison, WI). The results were compared with
the RPE65 reference sequence. Direct sequencing was used
to  investigate  the  presence  of  a  novel  variation  in  200
unrelated  healthy  Chinese  control  subjects  to  exclude
nonpathogenic polymorphisms. Cosegregation analysis was
performed in available family members. Multiple sequence
alignment  of  eight  eukaryotic  RPE65  homologs  was
performed  and  analyzed  with  an  online  analysis  tool
(HomoloGene).  We  also  assessed  the  potential  functional
consequences  of  nucleotide  changes  using  the  online
bioinformatics tool PolyPhen.
RESULTS
Patient demographics: One hundred and one patients in 100
unrelated  families  with  a  clinical  diagnosis  of  LCA  were
recruited for the study. All patients were of Chinese ethnicity.
Only one patient was born of a consanguineous marriage.
Mutation  analysis:  Sequence  analysis  of  the  RPE65  gene
identified  one  novel  missense  mutation  Leu67Arg  (c.
200T>G)  and  one  previously  reported  missense  mutation
Tyr368Cys  (c.1103A>G)  in  a  family  with  two  affected
patients (Figure 1) [14]. The two affected sisters carried the
mutations  in  compound  heterozygous  form.  The  mother
carried the Leu67Arg mutation on one RPE65 allele, and the
father carried the Tyr368Cys mutation on one RPE65 allele.
The novel Leu67Arg mutation identified in this study was
absent in 200 unrelated healthy Chinese control subjects and
is highly conserved through the species, strongly indicating
the pathogenicity of this novel missense variant (Figure 2).
The novel variant was predicted to be “probably damaging”
by PolyPhen. Four previously reported polymorphisms were
identified in this study (Table 1, SNP).
Clinical assessment:
The 13-year-old proband (II:1) This affected girl had
received a clinical diagnosis of retinitis pigmentosa at the age
of 9 years and was referred to PUMCH for further evaluation.
Her visual function was poor, and visual acuity was markedly
decreased in dimmer conditions. Her best corrected visual
acuity (BCVA) was 20/100 (OD) and 20/200 (OS) at the age
of 9 years. The refractions were +2.50DS-3.00DC×165° (OD)
and  +3.00DC×105°  (OS).  Intermittent  nystagmus  was
present. Color fundus montages showed mildly attenuated
retinal vessels, normal foveal reflexes, and numerous grayish
deposits in the midperipheral retina (Figure 3A). ERG was
found to be almost unrecordable (Figure 4). When the proband
was examined at her present age of 13, her BCVA was 20/100
in the right eye and 20/80 in the left eye. Her binocular vision
reached 20/60. Nystagmus was noted. OCT showed an almost
normal retinal microstructure with a detectable but thinned
photoreceptor layer (Figure 3C).
The 7-year-old affected sister (II:2) This affected sister
had a similar complaint of visual defect as her older sister. On
examination,  her  visual  acuity  was  20/80  (OU).  The
refractions were +7.00DS+1.00DC×80° (OD) and +6.50DS
+1.00DC×120° (OS). Her visual acuity increased to 20/60
(OU) during the two-year follow-up. Mild nystagmus was
observed.  The  anterior  segment  was  normal.  Fundus
examination showed minimal attenuation of retinal vessels
and  many  whitish  punctuate  lesions  in  the  midperipheral
retina  (Figure  3B).  An  extensively  thinned  photoreceptor
layer was documented with an OCT scan (Figure 3D). ERG
recordings showed extinguished rod responses and severely
diminished but recordable cone responses (Figure 4).
DISCUSSION
The  frequencies  of  mutations  in  the  RPE65  gene  vary
remarkably in different populations. With the study presented
here,  we  report  one  novel  and  one  previously  reported
mutation in the Chinese cohort. Our study reveals a prevalence
of 1% (1/100) in LCA cases due to RPE65 mutations. This
finding is similar to the findings in studies from India (1.7%)
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China (5.7%) [13]. A possible reason for this difference could
be  the  different  enrollment  criteria.  As  mutation  in  the
RPE65 gene may be related to LCA, severe early childhood
onset retinal dystrophy, or even autosomal-dominant retinitis
pigmentosa  [15,16],  different  enrollment  criteria  may
generate  different  positive  results.  However,  according  to
previous studies, the variant frequency for the RPE65 gene
was no more than 6% in Asian patients with LCA, indicating
that RPE65-associated LCA is rare in Asia.
Previous  studies  have  demonstrated  that  mutations  in
RPE65 may cause profound visual impairment at birth, and
transient improvement with useful vision persisting up to the
second decade [17-19]. A similar result was obtained in the
current study: the proband had poor visual acuity in the first
decade but showed mild improvement in BCVA when she was
examined at the age of 13. The improvement in the visual
Figure  1.  Sequence  analysis  of  the
RPE65  gene  missense  mutation
Leu67Arg (c.200T>G) and Tyr368Cys
(c.1103A>G)  in  a  family  with  two
affected patients. A: A Chinese family
with Leber congenital amaurosis (LCA)
harbors mutations in the retinal pigment
epithelium-specific  protein  65  kDa
(RPE65)  gene.  Squares  indicate  men;
circles, women; black symbols, affected
individuals; and the arrow indicates the
proband.  B:  The  figure  shows
sequencing results of the mutations in
this family.
Figure 2. The figure shows multiple sequences alignment for genetic variants of the retinal pigment epithelium-specific protein 65 kDa
(RPE65) gene in different species. The amino acids boxed in red indicate the position of Leu67Arg in the present study. This mutation occurs
in highly conserved region.
TABLE 1. POLYMORPHISMS DETECTED IN 100 UNRELATED LCA PATIENTS
ID Chr:bp Alleles HGVS names Type Amino acid Number of
patients
rs2274321 1:68906514 G/A ENST00000262340.5: c.
643+22C>T
Intronic - 3
rs12564647 1:68896945 T/G ENST00000262340.5: c.
1338+20A>C
Intronic - 27
rs12145904 1:68903942 C/T ENST00000262340.5: c.
1056G>A
Synonymous coding E352E 26
rs10626313 1:68894733–
68894732
-/CT ENST00000262340.5:c.*726_*72
7insAG
3 prime UTR - 9
          SNP website used.
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746Figure 3. Fundus photograph and optical coherence tomography pictures of the two patients with retinal pigment epithelium-specific protein
65 kDa (RPE65) mutations. A and C: patient II:1; B and D: patient II:2.
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747function  in  the  proband  and  her  younger  sister  may  be
interpreted as pointing to epigenetic regulatory mechanisms
induced by hormonal changes during puberty [20].
The two patients demonstrated normal appearance of the
central retina; furthermore, relatively preserved central retinal
architecture  was  shown  with  OCT.  According  to  a  study
conducted by Dr. Paunescu [18], the funduscopic appearance
of patients with RPE65 mutations was normal or showed
minor changes in the first decade. From the second decade on,
most  patients  had  progressive  macular  and/or  peripheral
changes. Our result was consistent with this study and further
verified the theory that patients with RPE65 mutations have
better visual functions than typically seen in LCA. However,
the retinal experience in these two patients was not exactly the
same. The proband’s younger sister showed evidence of fine
white retinal dots. This phenotype is not frequently observed
in patients with RPE65-associated LCA. The white retinal
dots may represent abnormal accumulations of retinyl esters,
as has been demonstrated in animal models [21,22].
To date, multiple missense mutations in the RPE65 gene
have  been  identified  in  patients  with  inherited  retinal
dystrophies, and a wide range of disease severity has been
associated with RPE65 mutations, from congenital blindness
LCA to adult-onset retinitis pigmentosa. With these initial
reports, a possible link between the severity of the disease and
the  type  of  mutations  in  the  RPE65  gene  remains  to  be
elucidated  [23-25].  RPE65  is  an  abundant  membrane-
associated protein in the retinal pigment epithelium, and this
characteristic  membrane  association  is  essential  for
isomerohydrolase activity. Previous studies have shown that
some missense mutations may lead to the instability as well
as the mislocalization of RPE65, thus severely impairing its
catalytic  activity  [26,27].  However,  different  missense
mutations at the same residual may have different levels of
influence on enzymatic activity [28]. The exact impacts of the
two point mutations identified in the current study on the
structure and function of RPE65 remain to be discovered.
Until  recently,  almost  all  types  of  inherited  retinal
degenerations,  such  as  LCA,  were  considered  incurable.
However, gene therapy has lit a candle in the dark. In 2008,
three  human  gene  therapy  clinical  trials  were  reported
involving  a  subretinal  injection  of  adeno-associated  virus
vector delivering a wild-type copy of RPE65. Most patients
exhibited some improvement in visual function, and there
were no obvious adverse events [29-31]. Identifying patients
with  mutations  in  the  RPE65  gene  has  attained  greater
significance now that gene replacement trials have begun.
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